Pharmaceuticals

Watson Pharmaceuticals and Arrow Group Receive FTC Second Request

MORRISTOWN, N.J., Aug. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today announced that it has received a request for additional information from the Federal Trade Commission ("FTC") in connection with Watson's...

Transcept Pharmaceuticals to Report Second Quarter 2009 Results

RICHMOND, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, ...

Bellicum Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial of Novel Vaccine for Patients With Advanced Prostate Cancer

HOUSTON, Aug. 6 /PRNewswire/ -- Bellicum Pharmaceuticals, Inc. today announced dosing of the first patient in a Phase I/II clinical trial of BP-GMAX-CD1, a novel pharmacologically regulated dendritic cell vaccine for the treatment of prostate cancer. The disease-specific trial is be...

Sagent Pharmaceuticals Announces Launch of First Two Oncolytic Products: Fludarabine Phosphate for Injection, USP and Epirubicin Hydrochloride Injection

SCHAUMBURG, Ill., Aug. 5 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced that it has launched fludarabine phosphate for injection, USP and epirubicin hydrochloride injection. IMS data indicates the combined U.S. market...

Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma

RESEARCH TRIANGLE PARK, N.C., Aug. 5 /PRNewswire/ -- Addrenex Pharmaceuticals, a specialty pharmaceutical company dedicated to developing treatments to regulate the adrenergic system, announced today an exclusive partnership with Dream Pharma. In keeping with its long-range plan to ...

Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment

PARSIPPANY, N.J., Aug. 4 /PRNewswire/ -- Ferring Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved the trade name FIRMAGON(R) (degarelix for injection) for its prostate cancer treatment previously marketed under the generic name degarelix. FIRMAGON...

Valeant Pharmaceuticals Reports Second Quarter Financial Results

ALISO VIEJO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX ) today announced second quarter financial results for 2009. "The second quarter once again demonstrated the strength of our diversified business model...

Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth Conference

CARLSBAD, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at the 29th Annual Canaccord Adams Global Growth Conference on Tuesday, August 11, 2009, ...

Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG

MORRISTOWN, N.J., Aug. 3 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration...

Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments

SAN DIEGO, Aug. 3, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) today reported financial results for the second quarter ended June 30, 2009. Arena reported a lower net loss allocable to common stockholders in the second quarter of 2009 of...

More>>

Pharmaceuticals in Medical Technology

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

DALLAS, Aug. 3 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), provided an update today on its clinical development strategy for ProLindac , a novel DACH platinum drug that has shown to be active in many solid tumors in human cli...

Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing

SOUTH SAN FRANCISCO, Calif., July 21 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on innovative oncology therapies, today announced results from a Phase 1 cardiac safety study of picoplatin, a new generation platinum-...

Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

CAMBRIDGE, Mass., July 20 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has successfully completed a three-day...

Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome

AIEA, Hawaii, July 20 /PRNewswire/ -- The Centers for Disease Control and Prevention reported this week that the prevalence of obesity among Americans is now over 26%. Obesity exacerbates a constellation of diseases including diabetes, liver disease, and heart disease, often in...

BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza

BIRMINGHAM, Ala., July 17 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals (Nasdaq: BCRX ) today announced positive results from two Phase 3 studies of intravenous (i.v.) peramivir in patients with seasonal influenza. The studies were sponsored by BioCryst's partner Shionogi & Co.,...

Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences

CORK, Ireland, July 16 /PRNewswire/ --Tibotec Pharmaceuticals today announced that it has entered into a license and collaboration agreement with Gilead Sciences, Inc. for the development and commercialization of a new once-daily fixed-dose antiretroviral product containing Tibotec's inv...

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

BELLEVILLE, Ontario and CHADDS FORD, Pa., July 10 /PRNewswire-FirstCall/ -- Bioniche Life Sciences Inc. (TSX: BNC) and Endo Pharmaceuticals (Nasdaq: ENDP ) jointly announced today that Endo has licensed from Bioniche the exclusive rights to develop and market Urocidin(TM) in the U.S. with ...

Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets

CINCINNATI, July 7 /PRNewswire/ -- Procter & Gamble Pharmaceuticals (P&GP) announced today the availability of Asacol HD (mesalamine) delayed-release tablets, which are indicated for the treatment of moderately active ulcerative colitis (UC), a form of inflammatory bowel disease. UC involv...

King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use

ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc. (NYSE: KG ) today announced that the Company is presenting safety and efficacy data for ACUROX(R) and EMBEDA(TM) (ALO-01...

Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints

Preliminary top-line results of second Phase III study show highly significant decreases in pain and fatigue and improved daily function in fibromyalgia patients and confirm results from the first Phase III study PALO ALTO, Calif., and BRUSSELS, June 24 /PRNewswire-FirstCall/ -- press releas...

More>>

Pharmaceuticals in Medical Products

21 CFR Pharma

Features:... Includes the parts 21 CFR 2005 edition focused on human pharmaceuticals Updated every weekday with new FR rules and proposed rules Bi-directional linking between 21 CFR parts and related FR amendments Based directly on ...
Company:Unbound Medicine, Inc.

Pharmaceuticals in Medical Definition

Nuclear medicine

...nd medical imaging that uses the nuclear properties of matter in diagnosis and therapy. Many procedures in nuclear medicine use radionuclides , or pharmaceuticals that have been labeled with radionuclides ( radiopharmaceuticals ). In diagnosis, radioactive substances are administered to patients and the radi...

Pharmaconomist

... Pharmaconomist ( Danish : farmakonom ) means expert in pharmaceuticals . Pharmaconomists are a pharmaceutically trained professional group in D...a pharmaconomist is also referred to as lægemiddelkyndig (i.e. expert in pharmaceuticals ). Lægemiddelkyndig comes from the Danish "lægemiddel" (meaning "pharmace...

Pharmaceuticals in Medical Dictionary

Tolmetin

...before taking Tolmetin ? ... PubChem Compound Summary ... Tolmetin - Substance Summary (SID 7849414) ... TOLMETIN SODIUM CAPSULES, USP [Mylan pharmaceuticals Inc. ... Tolmetin is used to relieve pain, tenderness, swelling, and stiffness caused by ... Tolmetin comes as a tablet and a ... Take tolmet...

Dubin

...iladelphia, Dubin Paper delivers to Southeastern Pennsylvania, New ... Dubin Medical Inc. Your Preferred National Distributor for Hard-To-Find pharmaceuticals - specializing in Biologicals, Injectables, and Vaccines. For over a decade Eric Dubin has been a highly successful trial attorney here in ... T...

CHEM

...nings in the Fall 2008 j. chem .tenn. ... Manufacturer- Distributor of guar, pigments, triclosan, sulfolane, menthol, castor oil ... Chemicals - pharmaceuticals - Pigments - Allied Products | Home | Products ... chemicals import export, purchase chemicals, peptide, antibiotics, Resins, amino acid, buy onli...

Pharmaceuticals in Biological News

Anadys Pharmaceuticals to Present at the Roth OC Growth Stock Conference

SAN DIEGO, Feb. 9 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today that it will present at the 21st Annual Roth OC Growth Stock Conference on Monday, February 16, 2009 at 1:00 p.m. PST (4:00 p.m. EST). The conference is being held at The Ritz-Carlton, Lagun...

Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design

HAYWARD, Calif., Nov. 27 /PRNewswire/ -- Singulex Inc. today announced that it is collaborating with researchers at Wyeth Research to develop immunoassays on the company's Erenna(TM) system. Singulex has installed the Erenna system at Wyeth as part of its Erenna Technology Access Program (ETAP...

Researchers develop liquid crystal pharmaceuticals to fight cancer and other diseases

A partnership between Kent State University, Summa Health System and IC-MedTech Inc. has yielded an innovative liquid crystal technology that offers the promise of new drugs which may more effectively manage cancer and other diseases. The American Cancer Society estimates that nearly 1.5 million n...

NMR researchers unlock hydrogen's secrets to spot polymorphism in pharmaceuticals

Researchers at the University of Warwick and Astra Zeneca have found a new way to use solid-state NMR equipment to crack the secrets of hydrogen atoms and thus spot unwanted polymorphs in pharmaceuticals. Pharmaceuticals companies are constantly battling the problem of polymorphism in which an ...

Bacteria from sponges make new pharmaceuticals

Thousands of interesting new compounds have been discovered inside the bodies of marine sponges according to scientists speaking today (Tuesday 4 September 2007) at the Society for General Microbiologys 161st Meeting at the University of Edinburgh, UK, which runs from 3-6 September 2007. Over h...

Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels

A team of scientists has discovered three molecules –?from a search of 58,000 compounds –?that appear to inhibit a key perpetrator of Alzheimer's disease. Each of the three molecules protects the protein called "tau," which becomes hopelessly tangled in the brains of patients with Alzheimer's. Th...

Advances in lung cancer research announced at conference

...nother presentation, Dr. Weiss discussed the release this week by Threshold pharmaceuticals Inc. and the Virginia G. Piper Cancer Center at Scottsdale Healthcare of re...he other, they are treated only with TH-302, which is produced by Threshold pharmaceuticals of Redwood City, Calif. In the study of those treated only with TH-302, ...

Marine microbes creating green waves in industry

...emical reactions we want to perform in industry. There is every possibility of developing more efficient and sustainable manufacturing solutions - for pharmaceuticals and agrochemicals in particular - as a result of this search." Microorganisms account for more than 95 per cent of ocean biomass but relatively lit...

CWRU receives $5 million from Ohio Third Frontier Commission

...o release a specific amount of drug over a prolonged period of time to tell the patient's cells to create cartilage. Bruce Trapp (CC) and Vertex pharmaceuticals of Cambridge, MA have identified a cell in the adult human brain and will evaluate its potential to treat a variety of neurodegenerative diseases and ...

UC Davis grant zeroes in on novel asthma diagnosis and treatment

... hypertension and inflammatory disorders, Hammock explained. "It's an enzyme in the same arachidonic biochemical pathway where many other common pharmaceuticals such as aspirin, Advil, Aleve, Ibuprofen, Motrin and others are active." The prevalence of asthma has increased 75 percent from 1980 to 1994, acc...

Pharmaceuticals in Biological Technology

Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes

EMERYVILLE, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it has agreed to sell an aggregate of four million shares of its common stock at a price to the public of $30.50 per share and $200 million aggregate principal amou...

Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009

ROCKVILLE, Md., Aug. 6 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA ), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced it will release r...

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial resul...

ADVENTRX Pharmaceuticals Announces Financing

SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) announced today that it has obtained a commitment to purchase shares of convertible preferred stock pursuant to a registered direct offering to a single institutional investor, representing gro...

Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock

CAMBRIDGE, Mass., Aug. 5 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten offering of...

Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results

SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) today reported financial results for the second quarter ended June 30, 2009. Optimer reported a net loss for the second quarter of 2009 of $12.4 million, or $0.37 per share, which was in lin...

Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia

NEW HAVEN, Conn., Aug. 5 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery, development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, today announced positive res...

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

SOUTH SAN FRANCISCO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on oncology, today reported financial results for the second quarter ended June 30, 2009, and provided a corporate update. "Duri...

Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist

JERUSALEM, Israel, August 4 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), a developer of oral delivery systems, today reported that its wholly owned Israeli subsidiary, Oramed Ltd., was awarded a government grant amounting to a total net amo...

Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level

SHANGHAI, Aug. 4 /PRNewswire-Asia/ -- Shanghai ChemPartner Co., Ltd., (ChemPartner) a wholly owned subsidiary of ShangPharma Corporation, announced today that it has moved its drug discovery collaboration with ELARA Pharmaceuticals to a new level. ChemPartner will provide fully integrated ser...

Pharmaceuticals in Biological Products

CM Glucose Broth from Aestus Pharmaceuticals Corp.

Description: Growth Medium / Media...
Company:Aestus Pharmaceuticals Corp.

Water, USP Purified/WFI G from Aestus Pharmaceuticals Corp.

Description: US Pharmacopoeia Purified-Water/Water-for-Injection Quality Water...
Company:Aestus Pharmaceuticals Corp.

CM Galactose Broth from Aestus Pharmaceuticals Corp.

Description: ...
Company:

Pharmaceuticals in Biological Definition

Biotechnology

...r promising new biotechnology application is the development of plant-made pharmaceuticals . Curiously, "biotechnology companies" need not employ "biotechnology" as...hiron Genzyme MedImmune Gilead Sciences Cephalon Millennium pharmaceuticals Biotechnology in fiction Star Trek The Breen use starship...

Monoclonal antibody

... ^ ORTHOCLONE OKT 3 Information page at Ortho Biotech . Retrieved 2005-03-10. ^ ZENAPAX (daclizumab) Information page at Roche pharmaceuticals . Retrieved 2005-03-10. ^ Novartis product page for Simulect (basiliximab for injection) . Retrieved 2005-03-09. ...

Retrovirus

...issing the usual "proofreading" of DNA transcription, this kind of virus mutates very often. This enables the virus to grow resistant to antiviral pharmaceuticals quickly, and is one of the main reasons why an effective vaccine for HIV has not been developed yet. Among others, retrovirus genomes commonly c...

Pharmaceuticals in Biological Dictionary

Phage

... former Soviet Union countries for about 90 years, this method of therapy is... Welcome to Phage Biotechnology Corp., A manufacturer of protein pharmaceuticals for human use. ... Us | Webmaster ©2009 Phage Biotechnology Corp. All Rights ... Actinoplanes phage phiAsp2. 58,638. AY576796. AY576796. 76 F...

Oligonucleotide

... oligonucleotide microarray design criteria to detect ... Supplying Every Link in the Peptide Chain – developed through the Mimotopes – Genzyme pharmaceuticals Global Alliance, providing seamless transition from supply of ... Oligonucleotide Oligo thermodynamic annealing temperature melting temperatu...

Epigenetic

...tions play a primordial role are described in detail. News and opinions on research and developments in the field of epigenetics. ... Constellation pharmaceuticals Aims to Develop Epigenetic Drugs ... Epigenetics is a term in biology used to refer to features such as chromatin and DNA modifications that ...